Dermatology News

Upadacitinib exhibited efficacy and a favorable benefit-risk profile for the long-term treatment of moderate to severe atopic dermatitis in adolescents, according to a study.

Scabies and impetigo prevalence was reduced significantly with mass administration of ivermectin or permethrin in small Indian communities, according to a study.

The CMS finalized cuts to the 2025 physician fee schedule for the fifth year in a row, prompting an urgent call-to-action from the American Academy of Dermatology. HHS, through the CMS, announced the finalization of the 2025 Medicare Physician Fee Schedule.

A previously healthy, 14-year-old girl is admitted to the hospital after complaints of painful swelling of her lower lip, with periodic spotty, blood-tinged drainage from several discrete areas with overlying dark scabs.

As kids return to school, the CDC has reminded the public that children with lice do not need to cut their school day short and be sent home early.

The FDA has granted rare pediatric disease designation to Descartes-08, an autologous mRNA cell therapy, for the treatment of juvenile dermatomyositis, Cartesian Therapeutics announced in a press release.

Fish oil supplementation during pregnancy was associated with children having a lower or higher risk for developing atopic dermatitis depending on the mother’s genotype, according to a study.

Radiotherapy and hematopoietic cell transplant increased the risk for keratinocyte carcinoma development in childhood cancer survivors, according to a study.

Children with diverse skin types with atopic dermatitis-prone skin did not experience any adverse events when using a sunscreen formulated with antioxidants, according to a study.